LRIG1 and cancer: In oral SCC cells, downregulation of leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) induced the activation of EGFR-mediated SphK1 signaling to promote extracellular matrix (ECM) remodeling and cancer cell progression [34].